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Glycogen synthase kinase 3 (GSK-3) is a key
component of the Wnt signalling pathway, among
others, and is known to be regulated by inhibition.
Now a novel, dual specificity protein kinase known as
Zaphod kinase has been discovered that activates
GSK-3 by tyrosine phosphorylation.
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The Hitchhiker’s Guide to the Galaxy [1] introduced Zaphod
Beeblebrox, an exotic alien with an ego so large that he
needs two heads. His name has now been adopted for a
novel protein kinase that contains two functional kinase
domains [2]. As with its two-headed namesake, Zaphod
kinase (ZAK1) promises to provide an alternative per-
spective of the world. It has already cast new light on the
regulation of glycogen synthase kinase 3 (GSK-3), a
multi-function and virtually universal protein kinase.
GSK-3 is now perhaps best known as a key component of
the Wnt signalling pathway that is so widely deployed in
animal development. As well as uncovering an intriguing
new type of protein kinase, the recent work on ZAK1 [2]
has shown that GSK-1 can be regulated by activating
tyrosine phosphorylation, as well as the better known
inhibitory mechanism.
Inhibition of GSK-3 by insulin and Wnt-1
To understand the significance of ZAK1, it is necessary
first to consider the regulation of GSK-3. GSK-3 was dis-
covered as one of the serine/threonine protein kinases that
phosphorylate glycogen synthase and thereby regulate
glycogen synthesis. These enzymes were, for obvious
reasons, named glycogen synthase kinases, or GSKs. Most
of these kinases have, however, also been identified in
different contexts, and are usually known by other names.
For example, GSK-1 is cAMP-dependent protein kinase
(PKA), whereas GSK-5 is commonly known as casein
kinase II. Despite the specificity inferred by its name,
GSK-3 has in fact turned out to be an important regulatory
kinase with a number of significant cellular targets.
Phosphorylation of glycogen synthase by GSK-3 inhibits
its activity in a manner that is reversed by insulin stimula-
tion [3]. Initially, direct regulation of GSK-3 by insulin
went undetected; this is not surprising, as it only causes a
50% reduction in GSK-3 activity. But coupled to the
action of the protein phosphatase PP1, this relatively small
change in the activity level of GSK-3 is sufficient to
control glycogen synthesis. It is now known that insulin
stimulates a phosphatidylinositide 3-kinase (PI 3-kinase)
to generate phosphatidylinositide 3,4,5-trisphosphate
(PIP3). This in turn activates protein kinase B (PKB),
which phosphorylates GSK-3 at a serine residue close to
its amino terminus This phosphorylation causes a reduc-
tion in  GSK-3 activity and leads to increased glycogen
synthase activity (Figure 1a). 
Much of the present interest in GSK-3 is due to its role in
the Wnt signalling pathway (Figure 1b). The Wnt family
of protein ligands control pattern formation during
metazoan development, and have also been linked to
oncogenesis. Central to this pathway is the degradation of
β-catenin, a process that is stimulated by direct phos-
phorylation through GSK-3. In the presence of Wnt,
β-catenin is stabilised and as a result the protein accumu-
lates, enters the nucleus and regulates transcription. This
response occurs through inhibition of GSK-3 in a complex
that also contains the proteins Axin, Dishevelled and
FRAT. GSK-3 binds to Axin, where it may phosphorylate
β-catenin. FRAT proteins, including their Xenopus homo-
logue GBP, bind to Dishevelled and inhibit GSK-3 activ-
ity. A current model is that Wnt stimulation controls entry
of Dishevelled into the Axin complex, and hence FRAT
inhibition of GSK-3 [4].
I have outlined the two well characterised regulatory
pathways for GSK-3. As both pathways when active
inhibit GSK-3, this has led to the belief that inhibition
may be the only means to control GSK-3 activity. Implicit
in this idea is the notion that all cells possess a high basal
activity of GSK-3, which is attenuated in response to cell
stimulation. This is an unusual situation, as most other
signal transduction pathways operate through cascades of
kinase activation. Is this generalisation true, or has GSK-3
activation been overlooked?
Anomalous regulation of GSK-3
A number of recent observations are not easily explained
by a purely inhibitory mechanism for the control of
GSK-3. In the nematode Caenorhabditis elegans, in contrast
to the fruitfly Drosophila or vertebrates, removal of GSK-3
activity has the same effect as loss of the Wnt homologue
(Mom-2) [5]. This suggests that Mom-2 has a positive
effect on GSK-3 activity in nematodes, rather than inhibit-
ing its activity. An important consideration here is that no
close Axin homologue has been identified in the nema-
tode genome, and therefore the model of Wnt signalling
described above may not apply. A further curious feature
bb10c09.qxd  02/29/2000  04:21  Page R116
observed in vertebrate systems is that GSK-3 activity is
required for its own interaction with Axin and also for
FRAT’s interaction with Dishevelled — in effect, GSK-3
activity is required for its own inhibition. Could GSK-3 be
activated by Wnt stimulation? If this were the case,
perhaps the net effect of stimulation in Drosophila and
vertebrates is for GSK-3 to bring about its own inhibition
by Dishevelled, whereas in nematodes, in the absence of
Axin, only GSK-3 activation is observed.
Two recent biochemical studies [6,7] have pointed to
pathways which increase GSK-3 activity (Figure 1c).
These both concern the phosphorylation of the neural
microtubule-binding protein, tau. This is of clinical
interest, as hyper-phosphorylation of tau by GSK-3 leads
to the formation of the paired helical filaments that are
associated with Alzheimer’s disease. Hartigan and
Johnson [6] found that a transient rise in cytosolic
calcium led to an increase in tau phosphorylation through
elevation of GSK-3 kinase activity. This was accompa-
nied by increased tyrosine phosphorylation of GSK-3.
Lesort et al. [7] found that insulin stimulation led to a tran-
sient increase in tau phosphorylation, before becoming
inhibitory over the long term. This dynamic response pro-
ceeded through a transient increase of GSK-3 activity and
was also associated with increased tyrosine phosphorylation
of GSK-3; the authors suggested that the tyrosine kinase
Fyn may be responsible for this phosphorylation.
In both of these cases, the changes observed in GSK-3
activity and phosphotyrosine content were small and hence
difficult to detect. Furthermore, the data do not adequately
distinguish between a direct activation of kinase activity
and an indirect mechanism involving inhibition of an
inhibitory pathway. But the recent work of Leung et al. [2],
using as a model system the simple eukaryote Dictyostelium,
has now provided both genetic and biochemical evidence
that GSK-3 can be activated through the tyrosine kinase
activity of the dual specificity kinase ZAK1 (Figure 2). 
ZAK1 and GSK-3 in Dictyostelium
Dictyostelium cells grow as unicellular amoebae, but when
starved they aggregate and undergo morphogenesis to
form a multicellular structure. This multicellular unit
contains three major structural elements: the spore head,
the stalk and the basal disc. GSK-3 is required to estab-
lish the patterning of these elements. In the absence of
GSK-3, an enlarged basal disc forms at the expense of the
spore head [8]. GSK-3 activity peaks as Dictyostelium cells
begin cell-type-specific differentiation, consistent with the
kinase playing a role in pattern formation. This increase of
GSK-3 activity is stimulated by extracellular cAMP, a
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Figure 1
(a) Insulin inhibits GSK-3 activity through the generation of
phosphatidylinositide (3,4,5) trisphosphate (PIP3) by the stimulation of
phosphatidylinositide 3-kinase (PI 3-kinase). This leads to the
activation of protein kinase B (PKB), which phosphorylates and inhibits
GSK-3 to alleviate inhibition of glycogen synthase. (b) Wnt-1
stimulation stabilises β-catenin by inhibiting the activity of GSK-3. This
occurs in a complex with Axin. Wnt stimulation may promote binding of
Dishevelled and FRAT to the complex, inhibiting GSK-3. These
interactions all require GSK-3 activity, raising the possibility that
activation of GSK-3 may lead to its own inhibition. β-catenin regulates
gene expression by interacting with the transcription factors TCF and
LEF. (c) GSK-3 phosphorylation of tau may proceed through activation
of GSK-3. This may be stimulated by insulin via the tyrosine kinase Fyn,
or through a transient increase of cytosolic Ca2+.
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signal that both induces spore precursor cells and represses
formation of basal disc precursors. When cAMP is added to
isolated Dictyostelium cells, GSK-3 activity rapidly increases
by a process that requires at least one of the organism’s
four cAMP receptors, identified as cAR3 [9]. 
This behaviour suggests that, during Dictyostelium
development, cAMP acts via cAR3 to increase GSK-3 activ-
ity, but this alone does not demonstrate direct activation.
The discovery of ZAK1 has provided this evidence [2].
ZAK1 was isolated in a screen for Dictyostelium tyrosine
kinases, and in fact has turned out to be an unusual dual
specificity protein kinase, containing both a tyrosine kinase
domain and a serine/threonine kinase domain. In that
respect, it resembles members of the JAK kinase family,
which phosphorylate the STAT transcription factors.
Unlike the JAKs, both kinase domains of ZAK1 are active.
Genetic disruption of ZAK1 caused a phenotype resem-
bling that of loss of GSK-3 or cAR3, suggesting that it acts
within the same activation pathway. Furthermore, cAMP
was found to increase the tyrosine kinase activity of ZAK1
with similar kinetics to that observed for GSK-3, and again
this increase requires cAR3. 
Does ZAK1 regulate GSK-3 activity? Loss of ZAK1 had
no effect on the GSK-3 protein level, but did cause a sig-
nificant reduction of GSK-3 kinase activity during devel-
opment. As seen with cAR3 mutants, in a ZAK1 mutant
cAMP stimulation failed to fully stimulate GSK-3 activity.
Significantly, recombinant ZAK1 protein will use GSK-3
as a substrate, and this phosphorylation leads to a doubling
of GSK-3 activity, the same degree of activation observed
in whole cells. Together, these results not only place
ZAK1 between cAR3 and GSK-3 on the cAMP response
pathway, they also demonstrate that ZAK1 interacts
directly with GSK-3 and can activate it in the absence of
other protein intermediates. 
Although no ZAK1 homologues have yet been identified in
other species, these results with Dictyostelium [2] establish
that tyrosine phosphorylation can positively regulate GSK-
3 activity. Having established the principle that activation
of GSK-3 can occur, this possibility should now be consid-
ered when investigating regulation of GSK-3 in other
systems. Indeed, comparing the observations made in Dic-
tyostelium with those for GSK-3 phosphorylation of tau sug-
gests the activation of GSK-3 may be widespread.
In the Hitchhiker’s Guide to the Galaxy, Zaphod Beeble-
brox and the other characters discover that they are on a
quest to find the answer to “life, the universe and every-
thing”. Back on Earth, a complete understanding of
GSK-3 regulation may not provide the answer to every-
thing, but the discovery of ZAK1 may lead us into new
territory for both the regulation of GSK-3 and signal
transduction in developmental systems.
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Figure 2
Dictyostelium cells develop to form a fruiting
body. This comprises a spore head, a stalk
and a basal disc. The proportion of spore and
basal disc cells is regulated by GSK-3, so that
in its absence an enlarged basal disc forms at
the expense of the spore head. ZAK1
activates GSK-3 activity and is regulated by
extracellular cAMP via the receptor cAR3.
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If you found this dispatch interesting, you might also want
to read the February 1999 issue of
Current Opinion in
Cell Biology
which included the following reviews, edited
by Joan S Brugge and Frank McCormick,
on Cell regulation:
Regulation of tyrosine kinase cascades by G-protein-
coupled receptors
Louis M Luttrell, Yehia Daaka and Robert J Lefkowitz
Epidermal growth factor receptors: critical mediators
of multiple receptor pathways
Peter O Hackel, Esther Zwick, Norbert Prenzel 
and Axel Ullrich
Multiple positive and negative regulators of signaling
by the EGF-receptor
Nadeem Moghal and Paul W Sternberg
Interactions between mitogenic stimuli, or, a thousand
and one connections
Martin A Schwartz and Veronique Baron
Costimulatory regulation of T cell function
Cynthia A Chambers and James P Allison
Organization and regulation of mitogen-activated
protein kinase signaling pathways
Timothy P Garrington and Gary L Johnson
Signalling through phosphoinositide 3-kinases: the
lipids take centre stage
Sally J Leevers, Bart Vanhaesebroeck and Michael D Waterfield
Multiple signals converging on NF-κB
Frank Mercurio and Anthony M Manning
Regulation of LEF-1/TCF transcription factors by Wnt
and other signals
Quinn Eastman and Rudolf Grosschedl
In or out? Regulating nuclear transport
Jennifer K Hood and Pamela A Silver
Organization and regulation of proteins at synapses
Jee Hae Kim and Richard L Huganir
Apoptosis control by death and decoy receptors
Avi Ashkenazi and Vishva M Dixit
Deciphering the pathways of life and death
Honglin Li and Junying Yuan
Regulating the onset of mitosis
Ryoma Ohi and Kathleen L Gould
Bidirectional signaling between the cytoskeleton
and integrins
Simone M Schoenwaelder and Keith Burridge
The full text of Current Opinion in Cell Biology is in the
BioMedNet library at
http://BioMedNet.com/cbiology/cel
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